Friday, November 8, 2019 Daily Archives

Accelerating Development and Manufacturing Platforms for Viral Vectors

by

This webcast features: Bai-wei Gu, Head of the Cell Line Development Group, WuXi Advanced Therapies Developing innovative advanced therapies is one of our greatest opportunities to dramatically improve patients’ lives. In this webinar, we will discuss our recent technical advancements in efficient viral vector manufacturing process development. From cell line development, to suspension culture of HEK293 cells, to media optimization and purification process, a series of improvements were implemented to advance our platform development for scalable large-scale manufacturing of viral…

November 8, 2019

Thermo to add culture media production capacity at Scotland site by 2021

by

Thermo Fisher Scientific will spend $24 million (€22 million) to up culture media capacity at its Inchinnan, Scotland facility. The firm said it will add large-volume liquid manufacturing capacity for cell culture media by 2021. Cory Stevenson, president of Thermo Fisher’s bioproduction business, said increased biopharmaceutical industry demand prompted the investment. “More and more customers are outsourcing their liquid manufacturing to ensure the highest quality while delivering efficiency.†“This investment will expand capabilities and expertise at our existing cell culture…

November 8, 2019

Pfizer unveils biosimilar launch plans and shares view on US market

by

Pfizer set out a busy programme of biosimilar launches in its Q3 call and shared its thoughts on the “rebate trough†and other challenges facing the US market. First the numbers. Pfizer finished the three months to the end of September with income of $7.7 billion (€7 billion) – up 87% on the year earlier quarter – and revenue of $12.7 billion, which is down 5% year-on-year. The revenue decline was due to Pfizer’s decision to merge its consumer unit with GSK’s…

November 8, 2019

Vetter to use robotics in aseptic production processes

by

Vetter says the use of artificial intelligence will become ever more specific in the biopharma production space and plans to use robotics in aseptic processes. German fill/finish and pharma services firm Vetter has completed a pilot project using a dual-arm robot in secondary packaging. “Robotics have been widespread in pharmaceutical manufacturing for many years. At Vetter, for example, we have been using classical robotics in our pharmaceutical production since the 1990’s,” Vetter spokesperson Markus Kirchner told this publication. “We see…

November 8, 2019